
    
      In this prospective trial, 100 patients with an acute SARS-CoV2 infection are enrolled. After
      confirmation of COVID-19, blood samples are taken for evaluation of various inflammatory
      cyokines and microvesicles at day 1, 5, 9 and 13 during hospitalisation and are interpreted
      in the context of clinical parameters.
    
  